News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

OUHSC Research News – Monday, September 20, 2021

Notices and Reminders

ORA Reminder: As a friendly reminder, please make sure you are carefully checking PeopleSoft and the budget justification to make sure OU Norman personnel are not included in the OUHSC personnel line.  Failure to properly list the OUHSC versus Norman personnel in the budget preparation phase may result in a rebudget request from the sponsor, and could negatively impact processing of the award.

NIH Policy Reminder: NIH awards are made to recipients, which are most often institutions, not individuals. NIH grants-policy staff members conduct official business with the Authorized Organization Representative (AORs), as detailed in NIHGPS Chapter 2.1.2 Recipient Staff.

As a reminder, inquiries regarding general grants-policy matters are best directed first to the recipient’s Office of Sponsored Programs; specifically, the AOR. In rare instances where these contacts are not able to assist in resolving the inquiry, or determine a need to seek guidance from the NIH on a complex or unusual policy circumstance, recipient/applicant’s AOR, not the PD/PI, may submit policy-related inquiries on the organization’s behalf to the NIH grants policy inbox.

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-151.html

Change to OUHSC new NIH Other Support pages requirements.  OUHSC will not start implementing this policy internally until October 01, 2021 (previously July 1, 2021).  Please keep in mind, that other institutions may have already implemented this policy and you may be required to use the new format for them before the OUHSC October 01, 2021 date.

 

Workshops and Seminars

Save the Date - ORA Noon Conference offered via Zoom

Date: September 29, 2021 at 1:00 pm

Topic: Writing Manuscripts

Description: Communicating the results of your research is an important part of the research enterprise. This presentation will cover how to write original articles and provide tools necessary to successfully write, submit, and publish a manuscript. It will introduce the purpose of each section of a research article, describe the recommended approach, and provide

information about common mistakes in writing for biomedical publications. APA’s Journal Article Reporting Standards (JARS) will also be introduced.

Registration: https://zoom.us/meeting/register/tJcvd-mopz4oHddDFLFtcGLzuQaM3nQpo8Sq

 

Lunch and Learn - Patents 101

Date: September 29, 2021, 12:00 pm

Description: First Do No Harm - How To Write and Speak about Your Invention Without Losing U.S. or Foreign Patent Rights.

We invite you to join us for an upcoming session of Innovation to Impact, a series of lunch discussions for faculty, staff and graduate students about the creation, management and commercialization of intellectual property (IP). This month's speaker is Chris Corbett, Director of Intellectual Property at OTD.

Join Zoom Meeting: https://oklahoma.zoom.us/j/92107292183?pwd=YzhCeG1sV0R2UlYxcndJK1lvUk1UUT09

 

Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS 

Deadline for abstracts: October 1, 2021

Abstracts must be received by 5 p.m. HHDC 2021 Research Symposium will be held VIRTUALLY on Friday, November 12, 2021. The Symposium will consist of selected oral presentations by faculty and Symposia talks by UTPAL PAJVANI, M.D., Ph.D., Associate Professor of Medicine, Columbia University, LORI SUSSEL, Ph.D., Professor of Medicine, University of Colorado Denver – Anschutz Medical Campus and KENT THORNBURG, Ph.D., Professor of Medicine, Oregon Health & Science University.

Additional details: https://www.ouhealth.com/harold-hamm-diabetes-center/diabetes-research/diabetes-lectures-seminars-visiting-professorshi/diabetes-research-symposium/

Questions: Katie-Hoefling@ouhsc.edu

 

NSF 2021 Fall Virtual Grants Conference

Date: October 4-8, 2021

Description: NSF has announced the 2021 Fall Virtual Grants Conference to be held October 4-8, 2021. For those who cannot attend the live conference, all recorded conference sessions will be available on-demand shortly after the event. Just like the in-person grants conferences, the NSF Virtual Grants Conference is a must, especially for new faculty, researchers, and administrators. The event is designed to give new faculty, researchers, and administrators key insights into a wide range of current issues at the National Science Foundation. NSF program officers will be providing up-to-date information about specific funding opportunities and answering attendee questions.

To learn more and to register, visit https://nsfpolicyoutreach.com/fall-21-virtual-conf/.

 

The Oklahoma Rural Health Conference
Date:
October 6-7, 2021, Edmond Conference Center

Description: This two-day event brings together rural health stakeholders to learn from experts in rural health and each other.

Registration: https://www.rhao.org/conference

 

OUHSC Funding Opportunities

Presbyterian Health Foundation (PHF) Bridge Grant Program Cycle III Request For Applications

Deadline: November 10, 2021

Description: The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques. This program can provide funding for up to $75,000 for one year. Guidelines and Application Form are attached for or can be found here.  If you have any questions, please email ORA4PHF@ouhsc.edu

Link to Full Announcement: https://research.ouhsc.edu/Resources/PHF-Funding-2021

 

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or meredith-wilkerson@ouhsc.edu).  

  • Midwest Drug Development Conference (https://www.mwdrugdevelopment.com ) is going virtual this October!  Please contact meredith-wilkerson@ouhsc.edu or otc@ou.edu  if you are developing a therapeutic and have supporting proof of concept data and are interested in pitching your technology to key decision-makers at pharmaceutical companies looking to expand their portfolio.  Also expected to be in the audience are investment groups who are interested in building or investing in startup companies.  Deadline 9/23.
  • one.five is a biotech platform startup company aiming to scale applied material science, specifically polymer coating technologies pertaining to paper or pulp-based substrates.  Out of scope: coating technologies that do not optimize coat weight or use of materials, technologies using rigid materials.  Research should be scalable to market within 1-5 years.  Submission entails a 1-pg non-confidential summary of technology (deadline 9/24).
  • Johnson & Johnson Innovation is seeking academic expertise and technologies related to the complement pathway which could play a role in systemic inflammatory or neuroinflammatory processes.  Targets of interest include: CR1, C3, MASP, and alternate complement pathway targets.  Out of scope: C5-C9 and drug repurposing approaches.  Submission entails a 1-pg non-confidential summary of technology (deadline 10/1).
  • Johnson & Johnson Innovation is seeking technologies focused on the mechanism of exosome uptake in the GI tract with a view of applying this knowledge to the oral delivery of macromolecules.  Preference is for technologies with data demonstrating in vitro transport correlates with in vivo transport and any species differences is advantageous.  Submission entails a 1-pg non-confidential summary of technology (deadline 10/15).

 

The University of Oklahoma Center for Health Equity

Deadline: October 1, 2021

Description: The goal of this proposed Center of Biomedical Research Excellence (COBRE) is to advance inquiry to address the persistent sources of health and health care inequality in Oklahoma. We seek to build core facilities to support this work and will partner with multiple departments at the University of Oklahoma (Norman Campus and Health Sciences Center) to develop a cadre of researchers pursuing studies in partnership with Oklahoma communities. We are requesting pre-proposals from qualified new investigators (tenure-track faculty without previous R01 funding) who are able to devote 6 months of effort to their proposed research project over a period of 2-3 years beginning in the fall of 2022. It is expected that research project leaders will transition to independent research at the end of their projects, thereby contributing to the ongoing development of research on health equity at the University of Oklahoma’s campuses. Interested candidates should submit a one-page overview (including specific aims) of their proposed research as a PDF file to Paul Spicer (paul.spicer@ou.edu) no later than October 1, 2021. Project budgets generally will not exceed $150,000 in direct costs for each year. Selection of the first cohort for the application will be made by October 15 with a draft of the full 6-page application expected by November 15.

 

NIH Notices

 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless  otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities:

 

Other Funding Opportunities

Michael W. Brown Scholarship

Deadline: September 22, 2021

Description: Mr. Brown served on the Board of the Rural Health Association of Oklahoma. A fund was established in his memory, which helps rural health advocates who would not have been able, due to budget issues, to attend the Oklahoma Rural Health Conference.

To apply, email agseigars@nwosu.edu by Wednesday, September 22 at 5pm with a paragraph about you, your current employment position, and why you are applying for the Michael W. Brown Scholarship.

 

The American Diabetes Association, Leveraging Nutrition and Lifestyle for Diabetes Prevention Across the Life Span

Deadline: Multiple dates, see announcement

Description: The American Diabetes Association is soliciting research to improve adoption of healthy diets and lifestyles at the individual and community level with interventions tailored to different racial and socioeconomic groups across the life span. Importantly, applicants should indicate how the proposed research will have a significant impact (“move the needle”) on outcomes in those individuals at risk of, or living with, diabetes. The goal of this RFA is to identify grants of the highest scientific merit, with greatest potential for successful outcomes and most innovative and transformative, for funding.

Link to Full Announcement: https://professional.diabetes.org/content-page/current-funding-opportunities-nutrition?utm_source=grants-email-091721

 

The American Diabetes Association, Leveraging Precision Medicine to Improve the Lives of People with Diabetes

Deadline: Multiple dates, see announcement

Description: The American Diabetes Association is soliciting research proposals that leverage precision medicine-based approaches at all stages in the course type 1 diabetes and type 2 diabetes. While this call is broad in scope and encompasses basic through clinical research, emphasis will be placed on clinical research and translation.

Importantly, submissions should indicate how the proposed research will have a significant impact (“move the needle”) on outcomes in those individuals living with diabetes.

Link to Full Announcement: https://professional.diabetes.org/content-page/current-funding-opportunities-precision-medicine?utm_source=grants-email-091721

 

DoD Melanoma Research Program Discovery Award

Required Letters of Intent Due: October 20, 2021

Applications Due: November 10, 2021

Link to Full Announcement: https://cdmrp.army.mil/funding/pa/FY21-MRP-DA.pdf

 

NSF Biology Integration Institutes

Applications Due: January 12, 2022

Link to Full Announcement: https://beta.nsf.gov/funding/opportunities/biology-integration-institutes-bii

 

NSF Integrative Research in Biology

Applications Due: January 25, 2022

Link to Full Announcement: https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf21622

Print

Documents to download